{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T03:13:50Z","timestamp":1752549230091,"version":"3.41.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"DOI":"10.1007\/s10689-025-00475-7","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T09:06:10Z","timestamp":1748250370000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pancreatic adenocarcinoma in a patient with a germline RB1 pathogenic variant"],"prefix":"10.1007","volume":"24","author":[{"given":"Riya","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Fountzilas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine M.","family":"Clayback","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik S.","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka K.","family":"Witkiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenan","family":"Onel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"issue":"7","key":"475_CR1","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1038\/s41416-020-01248-y","volume":"124","author":"SJ Schonfeld","year":"2021","unstructured":"Schonfeld SJ et al (2021) Long-term risk of subsequent cancer incidence among hereditary and nonhereditary retinoblastoma survivors. Br J Cancer 124(7):1312\u20131319","journal-title":"Br J Cancer"},{"key":"475_CR2","volume-title":"GeneReviews((R))","author":"DR Lohmann","year":"1993","unstructured":"Lohmann DR, Gallie BL (1993) Retinoblastoma. In: Adam MP et al (eds) GeneReviews((R)). University of Washington, Seattle"},{"issue":"9","key":"475_CR3","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/jnci\/djy227","volume":"111","author":"RA Kleinerman","year":"2019","unstructured":"Kleinerman RA et al (2019) Patterns of cause-specific mortality among 2053 survivors of retinoblastoma, 1914\u20132016. J Natl Cancer Inst 111(9):961\u2013969","journal-title":"J Natl Cancer Inst"},{"key":"475_CR4","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/978-1-4419-6448-9_21","volume":"685","author":"D Lohmann","year":"2010","unstructured":"Lohmann D (2010) Retinoblastoma. Adv Exp Med Biol 685:220\u2013227","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"475_CR5","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0002-9394(98)00146-9","volume":"126","author":"BG Mohney","year":"1998","unstructured":"Mohney BG et al (1998) Second nonocular tumors in survivors of heritable retinoblastoma and prior radiation therapy. Am J Ophthalmol 126(2):269\u2013277","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"475_CR6","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.3390\/cancers13061200","volume":"13","author":"AWM Fabius","year":"2021","unstructured":"Fabius AWM et al (2021) Subsequent malignant neoplasms in retinoblastoma survivors. Cancers 13(6):1200","journal-title":"Cancers"},{"issue":"22","key":"475_CR7","doi-asserted-by":"publisher","first-page":"5336","DOI":"10.3390\/cancers15225336","volume":"15","author":"D Figueiredo","year":"2023","unstructured":"Figueiredo D et al (2023) Risk of second tumors in retinoblastoma survivors after ionizing radiation: a review. Cancers 15(22):5336","journal-title":"Cancers"},{"issue":"9","key":"475_CR8","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/jama.2021.13027","volume":"326","author":"W Park","year":"2021","unstructured":"Park W, Chawla A, O\u2019Reilly EM (2021) Pancreatic cancer: a review. JAMA 326(9):851\u2013862","journal-title":"JAMA"},{"issue":"4","key":"475_CR9","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1101\/gad.275776.115","volume":"30","author":"H Ying","year":"2016","unstructured":"Ying H et al (2016) Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev 30(4):355\u2013385","journal-title":"Genes Dev"},{"issue":"5","key":"475_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2025.100709","volume":"38","author":"V Kryklyva","year":"2025","unstructured":"Kryklyva V et al (2025) Germline pathogenic variants in patients with pancreatic ductal adenocarcinoma and extra-pancreatic malignancies: a nationwide database analysis. Mod Pathol 38(5):100709","journal-title":"Mod Pathol"},{"issue":"1","key":"475_CR11","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/cancers16010056","volume":"16","author":"A Pantaleo","year":"2023","unstructured":"Pantaleo A et al (2023) Understanding the genetic landscape of pancreatic ductal adenocarcinoma to support personalized medicine: a systematic review. Cancers 16(1):56","journal-title":"Cancers"},{"issue":"7","key":"475_CR12","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1001\/jamaoncol.2023.0806","volume":"9","author":"X Chen","year":"2023","unstructured":"Chen X et al (2023) Risk of syndrome-associated cancers among first-degree relatives of patients with pancreatic ductal adenocarcinoma with pathogenic or likely pathogenic germline variants. JAMA Oncol 9(7):955\u2013961","journal-title":"JAMA Oncol"},{"issue":"1","key":"475_CR13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13053-022-00224-2","volume":"20","author":"M Olakowski","year":"2022","unstructured":"Olakowski M, Buldak L (2022) Current status of inherited pancreatic cancer. Hered Cancer Clin Pract 20(1):26","journal-title":"Hered Cancer Clin Pract"},{"issue":"10","key":"475_CR14","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1002\/ueg2.12662","volume":"12","author":"DCF Klatte","year":"2024","unstructured":"Klatte DCF et al (2024) Pancreatic cancer surveillance: risk stratification of individuals with a germline CDKN2A pathogenic variant. United Eur Gastroenterol J 12(10):1399\u20131403","journal-title":"United Eur Gastroenterol J"},{"issue":"1","key":"475_CR15","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/PPO.0000000000000011","volume":"20","author":"RW Cowan","year":"2014","unstructured":"Cowan RW, Maitra A (2014) Genetic progression of pancreatic cancer. Cancer J 20(1):80\u201384","journal-title":"Cancer J"},{"key":"475_CR16","doi-asserted-by":"publisher","first-page":"6744","DOI":"10.1038\/ncomms7744","volume":"6","author":"AK Witkiewicz","year":"2015","unstructured":"Witkiewicz AK et al (2015) Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets. Nat Commun 6:6744","journal-title":"Nat Commun"},{"issue":"15","key":"475_CR17","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.4161\/cc.10.15.16776","volume":"10","author":"AK Witkiewicz","year":"2011","unstructured":"Witkiewicz AK et al (2011) The meaning of p16(ink4a) expression in tumors: functional significance, clinical associations and future developments. Cell Cycle 10(15):2497\u20132503","journal-title":"Cell Cycle"},{"issue":"1","key":"475_CR18","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s42003-020-0873-9","volume":"3","author":"ES Knudsen","year":"2020","unstructured":"Knudsen ES et al (2020) Pan-cancer molecular analysis of the RB tumor suppressor pathway. Commun Biol 3(1):158","journal-title":"Commun Biol"},{"key":"475_CR19","first-page":"2147","volume":"62","author":"A Chou","year":"2017","unstructured":"Chou A et al (2017) Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer. Gut 62:2147","journal-title":"Gut"},{"issue":"1","key":"475_CR20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41698-023-00438-0","volume":"7","author":"AK Witkiewicz","year":"2023","unstructured":"Witkiewicz AK et al (2023) Determinants of response to CDK4\/6 inhibitors in the real-world setting. NPJ Precis Oncol 7(1):90","journal-title":"NPJ Precis Oncol"},{"issue":"10","key":"475_CR21","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1096\/fasebj.7.10.8393817","volume":"7","author":"KG Wiman","year":"1993","unstructured":"Wiman KG (1993) The retinoblastoma gene: role in cell cycle control and cell differentiation. FASEB J 7(10):841\u2013845","journal-title":"FASEB J"},{"issue":"6","key":"475_CR22","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/S0092-8674(00)81519-6","volume":"98","author":"JW Harbour","year":"1999","unstructured":"Harbour JW et al (1999) Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 98(6):859\u2013869","journal-title":"Cell"},{"issue":"8","key":"475_CR23","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1002\/ijc.27316","volume":"130","author":"H Rayess","year":"2012","unstructured":"Rayess H, Wang MB, Srivatsan ES (2012) Cellular senescence and tumor suppressor gene p16. Int J Cancer 130(8):1715\u20131725","journal-title":"Int J Cancer"},{"issue":"4","key":"475_CR24","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/onc.2011.250","volume":"31","author":"F Xing","year":"2012","unstructured":"Xing F et al (2012) Concurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF dependence in melanomas harboring (V600E)BRAF. Oncogene 31(4):446\u2013457","journal-title":"Oncogene"},{"issue":"2","key":"475_CR25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/his.14679","volume":"81","author":"G Papaxoinis","year":"2022","unstructured":"Papaxoinis G et al (2022) Comparative study of Rb1, cyclin D1 and p16 immunohistochemistry expression to distinguish lung small-cell carcinoma and large-cell neuroendocrine carcinoma. Histopathology 81(2):205\u2013214","journal-title":"Histopathology"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-025-00475-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-025-00475-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-025-00475-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T04:57:44Z","timestamp":1750913864000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-025-00475-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["475"],"URL":"https:\/\/doi.org\/10.1007\/s10689-025-00475-7","relation":{},"ISSN":["1573-7292"],"issn-type":[{"type":"electronic","value":"1573-7292"}],"subject":[],"published":{"date-parts":[[2025,5,26]]},"assertion":[{"value":"16 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"46"}}